Corporate Alliances
To support our product development and commercialization activities, we have pursued, and will selectively pursue, acquisitions or licenses to obtain proprietary pharmaceutical compounds or compound classes, formulation technologies, and intellectual property or other commercial assets.
We believe that strategic acquisitions may provide an effective means to broaden our product lines, enhance our revenue opportunities and diversify or add selected commercialization capabilities, such as sales and marketing, manufacturing, or product development.
Read more about Partnering Opportunities or our existing Corporate Partners.
About Us
Quick Links
© Copyright 2011 Angiotech. All Rights Reserved.